Polymethine compounds and their use as fluorescent labels

US9309409B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9309409-B2
Application numberUS-201514705844-A
CountryUS
Kind codeB2
Filing dateMay 6, 2015
Priority dateMay 7, 2014
Publication dateApr 12, 2016
Grant dateApr 12, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to new compounds and their use as fluorescent labels. The compounds may be used as fluorescent labels for nucleotides in nucleic acid sequencing applications.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of formula (I) or mesomeric forms thereof: wherein mCat+ or mAn− is an organic or inorganic positively/negatively charged counterion and m is an integer 0-3; n is an integer 1-5; Rf represents OH or O − ; or an ester or amine conjugate linked to a substrate moiety; each of Ra 1 and Ra 2 is independently H, SO 3 − , sulfonamide, halogen, or a further ring fused to an adjacent carbon atom; wherein either Ra 1 or Ra 2 is sulphonamide or SO 3 − ; and each of Rc 1 and Rc 2 is independently alkyl or substituted alkyl; wherein when Ra 1 or Ra 2 is SO 3 − , either i) Rc 1 or Rc 2 is an alkyl sulfonic acid group, or ii) Ra 1 or Ra 2 is a sulphonamide. 2. A compound according to claim 1 wherein Ra 1 is sulphonamide. 3. A compound according to claim 1 wherein Ra 2 is sulphonamide. 4. A compound according to claim 2 wherein Ra 2 is H or SO 3 − . 5. A compound according to claim 3 wherein Ra 1 is H or SO 3 − . 6. A compound according to claim 1 wherein Rc 1 or Rc 2 is methyl, ethyl, propyl or —(CH 2 ) q SO 3 − where q is 1-6. 7. A compound according to claim 6 wherein either Rc 1 or Rc 2 is (CH 2 ) 4 —SO 3 − . 8. A compound according to claim 1 wherein the sulphonamide is part of a structure of formula (II): wherein Rc 1 is alkyl or substituted alkyl. 9. A compound according to claim 1 wherein the sulphonamide is part of a structure of formula (III): wherein m is an integer 0-3, n is an integer 1-5, Rf is OH or O − ; and Rc 2 is alkyl or substituted alkyl. 10. A compound according to claim 1 which is represented by formula (IV): or a salt thereof wherein mCat+ or mAn− is an organic or inorganic positively/negatively charged counterion and m is an integer 0-3; n is an integer 1-5; and each of Rc 1 and Rc 2 is independently alkyl or substituted alkyl. 11. A compound according to claim 1 wherein the substrate moiety comprises a nucleotide or oligonucleotide. 12. A method of synthesizing a compound according to claim 1 , the method comprising reacting one of the following starting materials under conditions suitable for formation of a compound according to claim 1 : or a salt thereof wherein Ra is H, SO 3 − , sulfonamide, halogen, or a further ring fused to an adjacent carbon atom; R1, R2, R3 and R4 are independently H, alkyl or aryl; R c is alkyl or substituted alkyl; Ar is an aromatic group and R is an alkyl group. 13. A method of synthesising a compound according to claim 1 , the method comprising reacting one of the following starting materials under conditions suitable for formation of a compound according to claim 1 : or a salt thereof wherein n is an integer 1-5; Rc 2 is alkyl or substituted alkyl; Ar is an aromatic group and R is an alkyl group. 14. A compound according to claim 11 wherein the substrate moiety comprises a nucleotide. 15. A compound according to claim 11 wherein the substrate moiety comprises an oligonucleotide. 16. A compound according to claim 1 , wherein Rf represents an amine conjugate linked to a substrate moiety. 17. A compound according to claim 1 , wherein Rf represents an ester conjugate linked to a substrate moiety.

Assignees

Inventors

Classifications

  • C12Q1/6876Primary

    Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes · CPC title

  • the polymethine chain containing an odd number of >CH- {or >C[alkyl]-} groups · CPC title

  • C09B23/083Primary

    five >CH- groups · CPC title

  • C07D403/06Primary

    linked by a carbon chain containing only aliphatic carbon atoms · CPC title

  • C07D209/08Primary

    with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9309409B2 cover?
The present disclosure relates to new compounds and their use as fluorescent labels. The compounds may be used as fluorescent labels for nucleotides in nucleic acid sequencing applications.
Who is the assignee on this patent?
Illumina Cambridge Ltd
What technology area does this patent fall under?
Primary CPC classification C12Q1/6876. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).